NCT02217410 - CCFZ533X2201 - PoC Study in de Novo Renal Transplantation | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

February 5, 2015

Primary Completion Date

November 29, 2017

Study Completion Date

November 29, 2017

Conditions

Kidney Transplantation

Interventions

BIOLOGICAL

CFZ533

DRUG

Tacrolimus (Tac)

DRUG

Mycophenolate mofetil (MMF)

DRUG

Corticosteroids (CS)

BIOLOGICAL

anti-IL2 Induction

Trial Locations (14)

20246

Novartis Investigative Site, Hamburg

21201

Novartis Investigative Site, Baltimore

45147

Novartis Investigative Site, Essen

48202

Novartis Investigative Site, Detroit

69120

Novartis Investigative Site, Heidelberg

80045

Novartis Investigative Site, Aurora

48109 5271

Novartis Investigative Site, Ann Arbor

07039

Novartis Investigative Site, Livingston

45267-0585

Novartis Investigative Site, Cincinnati

04038-002

Novartis Investigative Site, São Paulo

D-13353

Novartis Investigative Site, Berlin

3508 GA

Novartis Investigative Site, Utrecht

9713 GZ

Novartis Investigative Site, Groningen

3000 CA

Novartis Investigative Site, Rotterdam